Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 23Genitourinary 5Thoracic 4Gastrointestinal 3Head & Neck 2Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 88Head and Neck Neoplasms 42Carcinoma, Non-Small-Cell Lung 32Melanoma 27Carcinoma, Renal Cell 24Colorectal Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Hepatocellular 14Ovarian Neoplasms 13Neoplasm Metastasis 13Carcinoma, Squamous Cell 13Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Carcinoma, Merkel Cell 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 10Nasopharyngeal Carcinoma 10Oropharyngeal Neoplasms 8Thyroid Neoplasms 7Urinary Bladder Neoplasms 6Small Cell Lung Carcinoma 6Sarcoma 6Recurrence 6Breast Neoplasms 6Mouth Neoplasms 5Lymphoma 5Lung Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Salivary Gland Neoplasms 4

Interventions

pembrolizumab 8Radiotherapy 2Nivolumab 2Drug Therapy 2Biopsy 2pertuzumab 1liposomal doxorubicin 1cemiplimab 1cc-486 1brodalumab 1atezolizumab 1Trastuzumab 1Therapeutics 1Surveys and Questionnaires 1Semaxinib 1SUB1 protein, human 1Radiosurgery 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Lighting 1Isotretinoin 1Interleukin-2 1Interferon-alpha 1Injections 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Neoplasms × Nivolumab × Head & Neck × Clear all
NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

DEKA Biosciences

Phase 1 Active not recruiting
39 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT03012581 2024-02-28

AcSé

UNICANCER

Phase 2 Completed
269 enrolled
DermatologicGenitourinaryHead & Neck

Carcinoma, Renal Cell, Head and Neck Neoplasms, Penile Neoplasms, Skin Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡